Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
4.45M
-
Shares change
-
+1.2M
-
Total reported value, excl. options
-
$7.96M
-
Value change
-
+$2.18M
-
Put/Call ratio
-
1.12
-
Number of buys
-
15
-
Number of sells
-
-6
-
Price
-
$1.79
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q1 2021
38 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q1 2021.
IGC Pharma, Inc. - COM NEW (IGC) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.45M shares
.
Largest 10 shareholders include BlackRock Inc. (911K shares), Davy Global Fund Management Ltd (835K shares), VANGUARD GROUP INC (714K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (490K shares), Carroll Financial Associates, Inc. (320K shares), GEODE CAPITAL MANAGEMENT, LLC (262K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (249K shares), Vontobel Holding Ltd. (120K shares), DEARBORN PARTNERS LLC (96.9K shares), and SIMPLEX TRADING, LLC (86.8K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.